Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept.

Brandt, Jan

Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept. [electronic resource] - The Journal of rheumatology Mar 2004 - 531-8 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study

0315-162X


Adult
Antirheumatic Agents--therapeutic use
Etanercept
Female
Humans
Immunoglobulin G--therapeutic use
Male
Middle Aged
Receptors, Tumor Necrosis Factor--therapeutic use
Recombinant Fusion Proteins--therapeutic use
Spondylitis--drug therapy
Treatment Outcome